WELCOME TO THE

COST ACTION CA20122 Harmonisation

Harmonizing clinical care and research on adrenal tumors in European countries

Read more

3rd call for the Short Term Scientific Missions (STSM)

The 3rd call for the Short Term Scientific Missions (STSM) applications for Missions occurring till 15/10/2024 is open. Deadline for applications to be submitted is 15/06/2024.

Read more
2-4 October 2024, Palma de Mallorca, Spain

The joint 23rd ENS@T and 3rd COST Harmonisation meeting

Dear friends and colleagues,

We are thrilled to invite you to participate in the 23rd edition of ENS@T Scientific Meeting and 3rd COST Harmonis@tion meeting, which will be held at the beautiful island of Palma de Mallorca (Spain). Mallorca Meeting will start on Wednesday, October 2nd at 14h and finish on Friday, October 4th at 13.30h.

Read more
01 March – 01 October 2024

Short Term Scientific Missions 2nd Call

The 2nd call for the Short Term Scientific Missions (STSM) applications for Missions occurring between 01/03/2024 and 01/10/2024 is open.

Deadline for applications to be submitted: 21/01/2024.

Read more

Latest news

EYES 2024

ECE 2024

Short Term Scientific Missions 1st Call

Join Harmonisation

Harmonis@tion is an open, interdisciplinary and growing network welcoming clinicians, scientists and relevant stakeholders to contribute to the activities of the action.

Join Us

Follow

COST

COST is an EU funding programme that enables researchers to set up their interdisciplinary research networks in Europe and beyond. We provide funds for organising conferences, meetings, training schools, short scientific exchanges or other networking activities in a wide range of scientific topics. By creating open spaces where people and ideas can grow, we unlock the full potential of science.

HARMONIS@TION

Harmonis@tion aims to constitute a multidisciplinary network to harmonize clinical care and research on adrenal tumours throughout Europe with a focus on COST Inclusiveness Target Countries. In addition, this collaborative network will establish a modern framework to develop a new generation of real-time and real-life randomized clinical trials, which will be federated and registry-based.

Action Details

Start of Action: 28/09/2021

End of Action: 27/09/2025